STVN News

Ensera startet Allianz-Netzwerk mit SHL Medical, der Stevanato Group, Ypsomed, Argonaut und American Injectables

Ensera lance un réseau de partenariat avec SHL Medical, Stevanato Group, Ypsomed, Argonaut et American Injectables

Ensera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables

Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting

Stevanato Group to Participate in Three Upcoming Investor Conferences

Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026

Stevens & Lee Expands in Pittsburgh, Adds Commercial Finance Attorney Megan Thompson as a Shareholder

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins